Curis (CRIS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.41, -20.18% vs the prior close of $0.51.
- Volume 1.32M shares, 5.3x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CRIS slides 20.2% to $0.41, a 52-week low on 5.3x normal volume. Closed at $0.41, -20.18% vs the prior close of $0.51. Day range $0.32–$0.45, opened at $0.45.
CRIS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CRIS slides 20.2% to $0.41, a 52-week low on 5.3x normal volume
- Closed at $0.41, -20.18% vs the prior close of $0.51. Day range $0.32–$0.45, opened at $0.45.
- Volume was 1.32M shares, 5.3x its 50-day average of 247.90K — unusually heavy trading.
- Price is -68.1% vs its 50-day average ($1.28) and -95.9% vs its 200-day average ($9.94).
- 52-week range $0.32–$33.60; today's close sits at 0% of that range, 98.8% below the 52-week high.
- That makes 12 straight losses.
Oct 15, 2026 — CRIS slides 15.0% to $0.51, a 52-week low on 2.0x normal volume
- Closed at $0.51, -15.00% vs the prior close of $0.60. Day range $0.47–$0.61, opened at $0.59.
- Volume was 489.40K shares, 2.0x its 50-day average of 239.20K — unusually heavy trading.
- Price is -62.4% vs its 50-day average ($1.36) and -94.9% vs its 200-day average ($10.04).
- 52-week range $0.47–$33.60; today's close sits at 0% of that range, 98.5% below the 52-week high.
- That makes 11 straight losses.
Oct 14, 2026 — CRIS dips 1.6% to $0.60, a 52-week low, 10 down days in a row
- Closed at $0.60, -1.64% vs the prior close of $0.61. Day range $0.57–$0.62, opened at $0.62.
- Volume was 123.00K shares, 0.5x its 50-day average of 238.45K — lighter than usual.
- Price is -58.3% vs its 50-day average ($1.44) and -94.1% vs its 200-day average ($10.14).
- 52-week range $0.57–$33.60; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 10 straight losses.
Oct 13, 2026 — CRIS slides 4.7% to $0.61, a 52-week low, 9 down days in a row
- Closed at $0.61, -4.69% vs the prior close of $0.64. Day range $0.59–$0.69, opened at $0.64.
- Volume was 210.30K shares, 0.9x its 50-day average of 235.93K.
- Price is -59.9% vs its 50-day average ($1.52) and -94.0% vs its 200-day average ($10.24).
- 52-week range $0.59–$33.60; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 9 straight losses.
Oct 12, 2026 — CRIS slides 4.5% to $0.64, a 52-week low, 8 down days in a row
- Closed at $0.64, -4.48% vs the prior close of $0.67. Day range $0.63–$0.69, opened at $0.68.
- Volume was 127.80K shares, 0.5x its 50-day average of 233.66K — lighter than usual.
- Price is -60.3% vs its 50-day average ($1.61) and -93.8% vs its 200-day average ($10.35).
- 52-week range $0.61–$33.60; today's close sits at 0% of that range, 98.1% below the 52-week high.
- That makes 8 straight losses.
Oct 9, 2026 — CRIS slides 5.6% to $0.67, a 52-week low, 7 down days in a row
- Closed at $0.67, -5.63% vs the prior close of $0.71. Day range $0.65–$0.72, opened at $0.72.
- Volume was 95.90K shares, 0.4x its 50-day average of 232.99K — lighter than usual.
- Price is -60.6% vs its 50-day average ($1.70) and -93.6% vs its 200-day average ($10.45).
- 52-week range $0.61–$33.60; today's close sits at 0% of that range, 98.0% below the 52-week high.
- That makes 7 straight losses.
Oct 8, 2026 — CRIS slides 4.1% to $0.71, a 52-week low on 1.9x normal volume
- Closed at $0.71, -4.05% vs the prior close of $0.74. Day range $0.61–$0.82, opened at $0.71.
- Volume was 426.50K shares, 1.9x its 50-day average of 225.80K — unusually heavy trading.
- Price is -60.2% vs its 50-day average ($1.78) and -93.3% vs its 200-day average ($10.55).
- 52-week range $0.61–$33.60; today's close sits at 0% of that range, 97.9% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — CRIS dips 1.3% to $0.74, a 52-week low, 5 down days in a row
- Closed at $0.74, -1.33% vs the prior close of $0.75. Day range $0.72–$0.79, opened at $0.79.
- Volume was 141.90K shares, 0.6x its 50-day average of 223.49K.
- Price is -60.4% vs its 50-day average ($1.87) and -93.1% vs its 200-day average ($10.65).
- 52-week range $0.72–$34.00; today's close sits at 0% of that range, 97.8% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — CRIS slides 5.1% to $0.75, a 52-week low, 4 down days in a row
- Closed at $0.75, -5.06% vs the prior close of $0.79. Day range $0.73–$0.77, opened at $0.77.
- Volume was 181.90K shares, 0.8x its 50-day average of 222.58K.
- Price is -61.6% vs its 50-day average ($1.95) and -93.0% vs its 200-day average ($10.76).
- 52-week range $0.72–$34.40; today's close sits at 0% of that range, 97.8% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — CRIS dips 1.2% to $0.79, a 52-week low on 2.6x normal volume
- Closed at $0.79, -1.25% vs the prior close of $0.80. Day range $0.72–$0.82, opened at $0.81.
- Volume was 556.30K shares, 2.6x its 50-day average of 213.63K — unusually heavy trading.
- Price is -61.1% vs its 50-day average ($2.03) and -92.7% vs its 200-day average ($10.87).
- 52-week range $0.72–$34.80; today's close sits at 0% of that range, 97.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — CRIS slides 3.6% to $0.80, a 52-week low
- Closed at $0.80, -3.61% vs the prior close of $0.83. Day range $0.80–$0.84, opened at $0.84.
- Volume was 100.20K shares, 0.5x its 50-day average of 212.98K — lighter than usual.
- Price is -62.1% vs its 50-day average ($2.11) and -92.7% vs its 200-day average ($10.99).
- 52-week range $0.80–$34.80; today's close sits at 0% of that range, 97.7% below the 52-week high.
CRIS latest news & SEC filings
Every SEC filing by or about CRIS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $2.75M) (-100.0% vs Jun 30, 2025)
- Net income: -$8.58M (prior year -$8.59M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$4.02 (prior year -$13.61) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 10, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 1, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Things to know before you trade CRIS
- Last results release: May 12, 2026 (8-K Item 2.02). Previous ones: Mar 19, 2026, Nov 6, 2025, Aug 5, 2025. Based on that rhythm, the next report is likely around Aug 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.67% (largest 20.2%). That is a volatile stock.
- Liquidity: about 265.05K shares (≈$107.90K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.41 vs a range of $0.32–$33.60 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Jul 6, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Kenneth I Kaitin bought 10,000 shares on Mar 31, 2026.
- Latest filings: 10-Q Aug 14, 2026; 8-K Jul 30, 2026; 8-K Jul 2, 2026.
- Share count: 2.09M shares outstanding (Aug 11, 2026), -83.3% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
CRIS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.45 | 0.45 | 0.32 | 0.41 | 1.32M |
| Oct 15, 2026 | 0.59 | 0.61 | 0.47 | 0.51 | 489.40K |
| Oct 14, 2026 | 0.62 | 0.62 | 0.57 | 0.60 | 123.00K |
| Oct 13, 2026 | 0.64 | 0.69 | 0.59 | 0.61 | 210.30K |
| Oct 12, 2026 | 0.68 | 0.69 | 0.63 | 0.64 | 127.80K |
| Oct 9, 2026 | 0.72 | 0.72 | 0.65 | 0.67 | 95.90K |
| Oct 8, 2026 | 0.71 | 0.82 | 0.61 | 0.71 | 426.50K |
| Oct 7, 2026 | 0.79 | 0.79 | 0.72 | 0.74 | 141.90K |
| Oct 6, 2026 | 0.77 | 0.77 | 0.73 | 0.75 | 181.90K |
| Oct 5, 2026 | 0.81 | 0.82 | 0.72 | 0.79 | 556.30K |
| Oct 2, 2026 | 0.84 | 0.84 | 0.80 | 0.80 | 100.20K |
| Oct 1, 2026 | 0.86 | 0.86 | 0.83 | 0.83 | 37.90K |
| Sep 30, 2026 | 0.83 | 0.86 | 0.83 | 0.84 | 92.20K |
| Sep 29, 2026 | 0.82 | 0.84 | 0.80 | 0.83 | 165.50K |
| Sep 28, 2026 | 0.84 | 0.86 | 0.80 | 0.83 | 158.30K |
| Sep 25, 2026 | 0.90 | 0.96 | 0.81 | 0.83 | 286.10K |
| Sep 24, 2026 | 0.97 | 0.99 | 0.86 | 0.88 | 308.40K |
| Sep 23, 2026 | 1.00 | 1.01 | 0.94 | 0.95 | 138.10K |
| Sep 22, 2026 | 0.98 | 1.07 | 0.97 | 1.00 | 159.20K |
| Sep 21, 2026 | 1.04 | 1.07 | 0.95 | 0.97 | 183.70K |
About Curis
Curis (CRIS) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in LEXINGTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1108205.
CRIS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Anne Elizabeth Borgman | Director | Jul 9, 2026 |
| James E Dentzer | President & CEO | Jul 9, 2026 |
| Martyn D Greenacre | Director | Jul 9, 2026 |
| John Hohneker | Director | Jul 9, 2026 |
| Kenneth I Kaitin | Director | Jul 9, 2026 |
| Marc Rubin | Director | Jul 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James E Dentzer | President & CEO | Jul 9, 2026 |
| Diantha Duvall | CFO | Jul 9, 2026 |
| Ahmed Md Hamdy | CMO | Mar 23, 2026 |
| Jonathan B. Zung | CDO | Jul 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 31, 2026 | Kenneth I Kaitin | Buy | 10,000 | $0.55 |
| Mar 31, 2026 | Kenneth I Kaitin | Buy | 10,000 | $0.55 |
| Mar 31, 2026 | Kenneth I Kaitin | Buy | 10,000 | $0.55 |
| Mar 31, 2026 | Kenneth I Kaitin | Buy | 10,000 | $0.55 |
CRIS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $9.44M | $-7.58M | -0.58 | $-27.20M |
| Dec 31, 2024 | $10.91M | $-43.39M | -6.88 | $-39.56M |
| Dec 31, 2023 | $10.02M | $-47.41M | -8.96 | $-38.43M |
| Dec 31, 2022 | $10.16M | $-56.67M | -12.14 | $-54.34M |
| Dec 31, 2021 | $10.65M | $-45.44M | 0.50 | $-37.62M |
Latest balance sheet: total assets $18.97M, total liabilities $14.28M, cash $5.07M (as of Jun 30, 2026).
CRIS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 12, 2026 | 8-K Item 2.02 (results) | $11.00 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $15.20 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $29.20 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $33.40 |
| May 6, 2025 | 8-K Item 2.02 (results) | $43.80 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $42.00 |
| Mar 28, 2025 | 8-K Item 2.02 (results) | $46.40 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $79.60 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CRIS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.